Abstract
Keywords: genetic engineering biological drugs, severe asthma, T2 inflammation, T2 asthma, genetic engineering biological therapy, interleukin, immunoglobulin E.
For citation:Danilov A.V., Argunova A.N., Soloveva Yu.A. Experience in the use of genetically engineered biological drugs for severe bronchial asthma in the Republic of Sakha (Yakutia). Clinical analysis in general medicine. 2024; 5 (1): 44–47 (In Russ.). DOI: 10.47407/kr2023.5.1.00359
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.